Patient's question:
We looked at many hospitals but couldn't find one.Doctor's answer:
The hepatitis B high-efficiency immunoglobulin has blood products but does not have a vaccine. Regarding the shortage of this drug, the disease control center is solely responsible for the tiered supply of vaccines but not for blood products. Currently, most of the hepatitis B immunoglobulin in this city is produced through aggregation, so once the supply is insufficient, it will again trigger a "chain reaction" of shortages across all hospitals in the city. "The manufacturer has no stock, and we can do nothing about it," the staff member speculated. The hepatitis B high-efficiency immunoglobulin is extracted from the blood of healthy individuals. Due to the decline in raw material costs, the cost of hepatitis B immunoglobulin has also fallen accordingly, but the national (highest retail price regulation) has not